Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Despite the paucity of extensive research, there have been anecdotal suggestions from researchers about the dosage of 5-amino-1MQ related to its oral bioavailability
AOD 9604 + NAD+ Combining AOD 9604 with NAD+ therapy at Perfect B in Doral targets two separate axes of metabolic function: NAD+ addresses cellular energy metabolism, mitochondrial efficiency, and metabolic resilience at the enzymatic level, while AOD 9604 drives fat mobilization from adipose tissue
NNMT is expressed abundantly in adipose tissue, where it has been associated with fat cell size and lipid storage dynamics
No dose-finding study with subcutaneous AOD-9604 has been published in a peer-reviewed journal indexed on PubMed
requires medical supervision The following guide provides comprehensive details on dosing calculations, administration technique, timing optimization, and safety protocols
5-Amino-1MQ is a first-in-class small molecule inhibitor designed to target Nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme that acts as a master regulator of the cellular "metabolic drain."
US$ 28.11
US$ 24.61
US$ 20.69
US$ 26.84
US$ 20.26
US$ 25.36
US$ 21.81
US$ 28.87
US$ 29.10
US$ 28.31